Antares has collaborated with Asembia to bring you TotalCare, the OTREXUPTM Injection Support Program. This unique program allows you to streamline the prescribing and prior authorization process for OTREXUPTM, without facing obstacles such as short-stocked pharmacies.
TotalCare will provide you with a simpler way to obtain benefits verification for your patient's OTREXUP prescription needs. Just enter your patient's prescription and insurance information once and TotalCare will perform not only the benefit's investigation but if needed a prior authorization as well. TotalCare will then help your patient to identify pharmacies in their area approved by their pharmacy insurance carrier that will stock OTREXUPTM. If needed, a pharmacy that is able to perform home delivery will be utilized to provide OTREXUPTM to your patient.
You can submit an OTREXUPTM prescription request online in 3 simple steps, and TotalCare will take care of the rest!
You may also complete any needed prior authorizations with minimal additional information as well.
For more details, download an information pdf Here
INDICATIONS:
Otrexup is indicated in:
Otrexup should not be used for the treatment of cancer.
Otrexup should not be used for the treatment of children with psoriasis.
This product includes the following Black Box Warning:
WARNING: SEVERE TOXIC REACTIONS, INCLUDING EMBRYO-FETAL TOXICITY AND DEATH
Otrexup should be used only by physicians whose knowledge and experience include the use of antimetabolite therapy. Because of the possibility of serious toxic reactions (which can be fatal), Otrexup should be used only in patients with psoriasis or rheumatoid arthritis with severe, recalcitrant, disabling disease which is not adequately responsive to other forms of therapy. Deaths have been reported with the use of methotrexate in the treatment of malignancy, psoriasis, and rheumatoid arthritis. Patients should be closely monitored for bone marrow, liver, lung, skin, and kidney toxicities. Patients should be informed by their physician of the risks involved and be under a physician’s care throughout therapy.
Otrexup is contraindicated in the following:
Warnings and Precautions:
Adverse Reactions
Common adverse reactions are: nausea, abdominal pain, dyspepsia, stomatitis/mouth sores, rash, nasopharyngitis, diarrhea, liver function test abnormalities, vomiting, headache, bronchitis, thrombocytopenia, alopecia, leucopenia, pancytopenia, dizziness, photosensitivity, and “burning of skin lesions”.
Drug Interactions
Use in Special Populations
Dosage and Administration
Otrexup is for once weekly subcutaneous use only.
Administer Otrexup in the abdomen or thigh.
For full prescribing information including boxed warning, please click here.
We could not match a prescriber with the information provided. Please select ‘OK’ to review your entry and try again.
For additional support please contact (855) 820-9605
One or more of the authentication questions were answered incorrectly.
The Prescriber has been found; checking status now.
You have not successfully completed the authentication process
For additional support please contact (855) 820-9605.
Congratulations! You have successfully completed the verification process.
The prescriber will be validated until 1/24/2022 10:53:24 PM